1068 related articles for article (PubMed ID: 15350294)
1. Nanoparticle and targeted systems for cancer therapy.
Brannon-Peppas L; Blanchette JO
Adv Drug Deliv Rev; 2004 Sep; 56(11):1649-59. PubMed ID: 15350294
[TBL] [Abstract][Full Text] [Related]
2. Active targeting schemes for nanoparticle systems in cancer therapeutics.
Byrne JD; Betancourt T; Brannon-Peppas L
Adv Drug Deliv Rev; 2008 Dec; 60(15):1615-26. PubMed ID: 18840489
[TBL] [Abstract][Full Text] [Related]
3. Targeted nucleic acid delivery into tumors: new avenues for cancer therapy.
Wagner E; Kircheis R; Walker GF
Biomed Pharmacother; 2004 Apr; 58(3):152-61. PubMed ID: 15082337
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle technologies for cancer therapy.
Alexis F; Pridgen EM; Langer R; Farokhzad OC
Handb Exp Pharmacol; 2010; (197):55-86. PubMed ID: 20217526
[TBL] [Abstract][Full Text] [Related]
5. Integrin targeted drug and gene delivery.
Wang Z; Chui WK; Ho PC
Expert Opin Drug Deliv; 2010 Feb; 7(2):159-71. PubMed ID: 20095940
[TBL] [Abstract][Full Text] [Related]
6. Exploiting the enhanced permeability and retention effect for tumor targeting.
Iyer AK; Khaled G; Fang J; Maeda H
Drug Discov Today; 2006 Sep; 11(17-18):812-8. PubMed ID: 16935749
[TBL] [Abstract][Full Text] [Related]
7. [Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance].
Chen JN; Shen Q; Li SS
Yao Xue Xue Bao; 2009 Apr; 44(4):333-7. PubMed ID: 19545047
[TBL] [Abstract][Full Text] [Related]
8. Use of nanoparticles for drug delivery in glioblastoma multiforme.
Jain KK
Expert Rev Neurother; 2007 Apr; 7(4):363-72. PubMed ID: 17425491
[TBL] [Abstract][Full Text] [Related]
9. Targeting strategies in cancer gene therapy.
Wang JH; Liu XY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):311-6. PubMed ID: 12673383
[TBL] [Abstract][Full Text] [Related]
10. Review: nanoparticles in drug delivery for the treatment of cancer.
Arayne MS; Sultana N
Pak J Pharm Sci; 2006 Jul; 19(3):258-68. PubMed ID: 16935836
[TBL] [Abstract][Full Text] [Related]
11. Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy.
Brumlik MJ; Daniel BJ; Waehler R; Curiel DT; Giles FJ; Curiel TJ
Expert Opin Drug Deliv; 2008 Jan; 5(1):87-103. PubMed ID: 18095930
[TBL] [Abstract][Full Text] [Related]
12. Overview of drug delivery and alternative methods to electroporation.
Hui SW
Methods Mol Biol; 2008; 423():91-107. PubMed ID: 18370192
[TBL] [Abstract][Full Text] [Related]
13. Engineered nanoparticles as precise drug delivery systems.
Yih TC; Al-Fandi M
J Cell Biochem; 2006 Apr; 97(6):1184-90. PubMed ID: 16440317
[TBL] [Abstract][Full Text] [Related]
14. Targeted drug delivery strategies to treat lung metastasis.
Bar J; Herbst RS; Onn A
Expert Opin Drug Deliv; 2009 Oct; 6(10):1003-16. PubMed ID: 19663628
[TBL] [Abstract][Full Text] [Related]
15. Composite nanoparticles take aim at cancer.
Gil PR; Parak WJ
ACS Nano; 2008 Nov; 2(11):2200-5. PubMed ID: 19206383
[TBL] [Abstract][Full Text] [Related]
16. Radiation-guided drug delivery systems.
Stacy DR; Lu B; Hallahan DE
Expert Rev Anticancer Ther; 2004 Apr; 4(2):283-8. PubMed ID: 15056058
[TBL] [Abstract][Full Text] [Related]
17. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
Maeda H; Bharate GY; Daruwalla J
Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle therapeutics: an emerging treatment modality for cancer.
Davis ME; Chen ZG; Shin DM
Nat Rev Drug Discov; 2008 Sep; 7(9):771-82. PubMed ID: 18758474
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of superparamagnetic CaCO3 mesocrystals for multistage delivery in cancer therapy.
Zhao Y; Lu Y; Hu Y; Li JP; Dong L; Lin LN; Yu SH
Small; 2010 Nov; 6(21):2436-42. PubMed ID: 20878636
[TBL] [Abstract][Full Text] [Related]
20. Drug delivery to tumours: recent strategies.
Reddy LH
J Pharm Pharmacol; 2005 Oct; 57(10):1231-42. PubMed ID: 16259751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
